Molecules (Dec 2022)

In Vitro Cytotoxic Effects and Mechanisms of Action of Eleutherine Isolated from <i>Eleutherine plicata</i> Bulb in Rat Glioma C6 Cells

  • Victoria Mae Tsuruzaki Shinkai,
  • Izana Marize Oliveira Sampaio,
  • Eline Gomes dos Santos,
  • Adan Jesús Galué-Parra,
  • Dionisia Pelaes Ferreira,
  • Drielly Dayanne Monteiro Santos Baliza,
  • Neidiane Farias Ramos,
  • Raphael Sanzio Pimenta,
  • Rommel Mario Rodriguez Burbano,
  • Chubert Bernardo Castro Sena,
  • Barbarella Matos Macchi,
  • Irlon Maciel Ferreira,
  • Edilene Oliveira Silva,
  • José Luiz Martins do Nascimento

DOI
https://doi.org/10.3390/molecules27248850
Journal volume & issue
Vol. 27, no. 24
p. 8850

Abstract

Read online

Gliomas are the most common primary malignant brain tumors in adults, and have a poor prognosis, despite the different types of treatment available. There is growing demand for new therapies to treat this life-threatening tumor. Quinone derivatives from plants have received increased interest as potential anti-glioma drugs, due to their diverse pharmacologic activities, such as inhibiting cell growth, inflammation, tumor invasion, and promoting tumor regression. Previous studies have demonstrated the anti-glioma activity of Eleutherine plicata, which is related to three main naphthoquinone compounds—eleutherine, isoeleutherine, and eleutherol—but their mechanism of action remains elusive. Thus, the aim of this study was to investigate the mechanism of action of eleutherine on rat C6 glioma. In vitro cytotoxicity was evaluated by MTT assay; morphological changes were evaluated by phase-contrast microscopy. Apoptosis was determined by annexin V–FITC–propidium iodide staining, and antiproliferative effects were assessed by wound migration and colony formation assays. Protein kinase B (AKT/pAKT) expression was measured by western blot, and telomerase reverse transcriptase mRNA was measured by quantitative real-time polymerase chain reaction (qRT-PCR). Eleutherine reduced C6 cell proliferation in a dose-dependent manner, suppressed migration and invasion, induced apoptosis, and reduced AKT phosphorylation and telomerase expression. In summary, our results suggest that eleutherine has potential clinical use in treating glioma.

Keywords